A. Teíchmann

Paracrine actions of oxytocin, prostaglandin F2 alpha, and estradiol within the human corpus luteum.

Stefan Maas, Hubertus Jarry, A. Teíchmann et al. · The Journal of Clinical Endocrinology & Metabolism · 1992 · 60 citations

Luteal Cell Culture, Cytoskeleton, Reproductive Endocrinology +18

Development of a novel nitric oxide (NO) production inhibitor with potential therapeutic effect on chronic inflammation

Youzhe Yang, Zhe Wei, A. Teíchmann et al. · European Journal of Medicinal Chemistry · 2020 · 54 citations

Inflammation, Anti-inflammatory, Potential Therapeutic Effect +8

FAM family gene prediction model reveals heterogeneity, stemness and immune microenvironment of UCEC

Hao Chi, Xinrui Gao, Zhijia Xia et al. · Frontiers in Molecular Biosciences · 2023 · 54 citations · Full text

Occurrence of antibodies TO L1, L2, E4 and E7 gene products of human papillomavirus types 6b, 16 and 18 among cervical cancer patients and controls

Heinrich G. Köchel, Masyar Monazahian, Kai Sievert et al. · International Journal of Cancer · 1991 · 52 citations

Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial

A. Teíchmann, Dan Apter, Janusz Emerich et al. · Contraception · 2009 · 48 citations

Open-label Trial, Hormonal Contraceptive, Daily Levonorgestrel/ethinyl Estradiol +8